-
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
Cons
Performance of Advanced Proteome Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Satellos Bioscience Inc. | -5.240% | 15.640% | 16.746% | -13.628% | 20.792% | 163.784% | - |
| Larimar Therapeutics Inc. | -1.400% | -3.425% | -16.071% | -21.667% | -15.060% | -26.943% | -83.174% |
| Vaxart Inc. | 24.240% | 50.735% | 46.429% | -47.503% | 46.429% | -54.545% | -92.407% |
News
2 Stocks That'll Be Worth More Than Nvidia 5 Years From Now
The increasing demand for all things artificial intelligence (AI) helped Nvidia emerge out of nowhere to become the world's largest company as measured by market cap. Between the $4.6 trillion
Stock Market Today, Jan. 8: Nvidia Slides as AI Demand Forecasts Top $500 Billion
Nvidia (NASDAQ:NVDA), a GPU and AI solutions leader, closed Thursday's session at $185, down 2.17%. Nvidia IPO'd in 1999 and has grown an astounding 450,934% since going public. Trading volume
Penguin Solutions: The Deep-Value AI Play You’ve Been Looking For
Penguin Solutions (NASDAQ: PENG) could be the deep value AI play you’ve been looking for. It's currently trading at pennies on the dollar relative to long-term forecasts—forecasts that may be


